N-ACETYLATION PHENOTYPE IN BLADDER-CANCER

被引：36

作者：

WOODHOUSE, KW ^{[1
]}

ADAMS, PC ^{[1
]}

CLOTHIER, A ^{[1
]}

MUCKLOW, JC ^{[1
]}

RAWLINS, MD ^{[1
]}

机构：

[1] CITY GEN HOSP,DEPT CLIN PHARMACOL,STOKE ON TRENT ST4 6QG,STAFFS,ENGLAND

来源：

HUMAN TOXICOLOGY | 1982年 / 1卷 / 04期

关键词：

D O I：

10.1177/096032718200100411

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：443 / 445

页数：3

共 7 条

[1] CLAYSON DB, 1975, BIOL CLIN MANAGEMENT, P65
[2] DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251
[3] EVANS DAP, 1964, J LAB CLIN MED, V63, P394
[4] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN
EVANS, DAP
MANLEY, KA
MCKUSICK, VA
[J]. BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) : 485 - 491
[5] HEPATIC DRUG ACETYLATION AND OXIDATION - EFFECTS OF AGING IN MAN
FARAH, F
TAYLOR, W
RAWLINS, MD
JAMES, O
[J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6080) : 155 - 156
[6] N-ACETYLTRANSFERASE PHENOTYPE AND RISK IN URINARY-BLADDER CANCER - APPROACHES IN MOLECULAR EPIDEMIOLOGY - PRELIMINARY-RESULTS IN SWEDEN AND DENMARK
LOWER, GM
NILSSON, T
NELSON, CE
WOLF, H
GAMSKY, TE
BRYAN, GT
[J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1979, 29 (APR) : 71 - 79
[7] MAHER JR, 1957, AM REV TUBERC PULM, V76, P852